Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Yokohama Rubber Co Ltd | 52 |
| 2 | Esteve Healthcare SL | 18 |
| 3 | Pfizer Inc | 16 |
| 4 | Kolon Industries Inc | 10 |
| 5 | Astellas Pharma Inc | 5 |
| 6 | C.H. Boehringer Sohn AG and Co KG | 5 |
| 7 | Goodyear Tire and Rubber Co | 5 |
| 8 | Rohto Pharmaceutical Co Ltd | 5 |
| 9 | Scripps Research Institute | 5 |
| 10 | Novartis AG | 4 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 98 |
| 2 | A61P | Therapeutic activity (drug indications) | 71 |
| 3 | B60C | 65 | |
| 4 | Y10T | Cross-reference (technical subjects) | 44 |
| 5 | B29D | 36 |
| 6 | C07D | Heterocyclic compounds | 33 |
| 7 | C08L | Polymer compositions (blends) | 22 |
| 8 | A61Q | Cosmetics, personal care | 17 |
| 9 | B32B | Layered products | 11 |
| 10 | A61N | 9 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| USE OF COMPOUNDS FOR THE TREATMENT OF PAIN | 2013 | 53 | |
| Pharmacological composition for topical administration | 1997 | 110 | |
| Pneumatic tire with air permeation preventive layer | 1999 | Yokohama Rubber Co Ltd | 97 |
| METHODS OF TREATING CORONAVIRUS INFECTION | 2015 | University System of Maryland | 33 |
| Pneumatic tire with air permeation preventive layer | 1998 | Yokohama Rubber Co Ltd | 71 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | E W Pommerenke | Heidelberg University | 2 |
| 2 | M Volm | Heidelberg University | 2 |
| 3 | H. Oßwald | Heidelberg University | 2 |
| 4 | B Christol | 1 | |
| 5 | H Veigel | 1 |
| 6 | Lawrence C. Weaver | Dow Chemical (United States) | 1 |
| 7 | Jacek M. Maselko | 1 | |
| 8 | T Pyzik | 1 | |
| 9 | David Brinkman‐Sull | Dow Chemical (United States) | 1 |
| 10 | P. R. Uldall | 1 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Simultaneous spectrophotometric determination of chlorphenoxamine hydrochloride and caffeine in a pharmaceutical preparation using first derivative of the ratio spectra and chemometric methods | 2002 | 51 | Analytical Chemistry and Chromatography |
| Anticonvulsant and antitremor effects of chlorphenoxamine. | 1961 | 12 | Neuroscience and Neuropharmacology Research |
| Reversing multidrug resistance in L1210 tumor cells by hycanthone or chlorophenoxamine in vitro and in vivo. | 1991 | 10 | Synthesis and biological activity |
| Simultaneous Determination of Caffeine, 8-Chlorotheophylline, and Chlorphenoxamine Hydrochloride in Ternary Mixtures by Ratio-Spectra Zero-Crossing First-Derivative Spectrophotometric and Chemometric Methods | 2005 | 10 | Analytical Methods in Pharmaceuticals |
| Urinary metabolism of chlorphenoxamine in man. | 1987 | 9 | Analytical Chemistry and Chromatography |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Chlorphenoxamine Hydrochloride?
Which organizations hold the most patents involving this compound?
What pharmaceutical and patent classification areas are most represented?
What research topics have been published on this compound?
What patent activity trend is observed for this compound in recent years?